NEW YORK, December 1, 2023 — In the third and final plenary panel of the inaugural Cure4Cancer Conference Advancing Global Health Equity and Harmonization hosted by Memorial Sloan Kettering Cancer Center (MSK), Chinese Thoracic Oncology Group (CTONG), and Asia Society Policy Institute (ASPI), experts discuss how to expand health equity in clinical trial access around the world. Participants include John V. Oyler, co-founder, CEO, and chairman of BeiGene; Jennifer Dent, president and CEO of BIO Ventures for Global Health (BVGH); Dr. Tolulope Adewole, managing director of NSIA Advanced Medical Services Limited (Medserve), Nigeria; Stephen Clarke, senior staff specialist medical oncologist at Royal North Shore Hospital; and Paulo Nigro, CEO at Hospital Sirio-Libanes, Brazil. Deb Schrag, chair of the Department of Medicine at Memorial Sloan Kettering Cancer Center, moderates the conversation. (44 min., 40 sec.)